The purpose of this study is to verify the effect of acute sodium bicarbonate (SB) and placebo (PLA) supplementation on buffering potential kinetics, physical capacity, discipline-specific performance as well as concentration of diagnostically significant blood biochemical indices in athletes, in a randomised, double-blind, placebo-controlled crossover trial.
Effective muscle work is conditioned by maintaining the proper range of muscles pH, regulated by buffering systems, in which the main role is played by bicarbonates (HCO3-). For this reason, sodium bicarbonate (SB) is often proposed as an ergogenic agent, especially during high-intensity efforts. Until now the major limitation to SB supplementation has been the gastrointestinal (GI) side effects. There is also a lack of data of the individual SB-induced changes of buffering potential kinetics and its actual connection with physical capacity and discipline-specific performance. Therefore, this study aims to examine the effect of acute, different-dose SB ingestion on buffering potential kinetics, physical capacity, discipline-specific performance as well as changes of diagnostically significant blood biochemical indices concentration in athletes, in a randomised, double-blind, placebo-controlled crossover trial.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
50
Interventions: The experimental procedure for each athlete included an acute SB supplementation in a different-dose regimen in order to assess whether the dose affects the actual physical and exercise capacity (doses: 0.15-, 0.25-, 0.35- and 0.50 g/kgFFM (0.12-, 0.20-, 0.28- and 0.40 g/kgBM), respectively). SB (Alkala, SANUM, Poland) will be administered as dissolved form in a 750 ml of fluid (water + fruit juice). On testing days the SB will be taken before physical and exercise capacity tests session. Between the SB and PLA or a PLA and SB treatments, a minimum 7-day washout period will be introduced.
Interventions: The experimental procedure for each athlete will be included an PLA supplementation. Placebo will be administered in a form of 750 ml of fluid (water + fruit juice). On testing days the PLA will be taken before physical and exercise capacity tests session. Between the PLA and SB or a SB and PLA treatments, a minimum 7-day washout period will be introduced.
Department of Sports Dietetics, Poznan University of Physical Education
Poznan, Poland
Changes in anaerobic capacity after sodium bicarbonate supplementation and placebo treatment
The Wingate cycling test carried out at baseline, and after SB and PLA supplementation
Time frame: Baseline and during 1 day of acute SB and PLA supplementation
Changes in discipline-specific exercise capacity after sodium bicarbonate supplementation and placebo treatment
The discipline-specific exercise capacity tests carried out at baseline, and after SB and PLA supplementation
Time frame: Baseline and during 1 day of acute SB and PLA supplementation
Changes of bicarbonate concentration in blood after sodium bicarbonate supplementation and placebo treatment
Bicarbonate (HCO3-) \[mmol/L\] concentration analysis in blood carried out at baseline, and after SB and PLA supplementation
Time frame: Baseline and during 1 day of acute SB and PLA supplementation
Changes of base excess concentration in blood after sodium bicarbonate supplementation and placebo treatment
Base excess \[mmol/L\] concentration analysis in blood carried out at baseline, and after SB and PLA supplementation
Time frame: Baseline and during 1 day of acute SB and PLA supplementation
Changes of pH in blood after sodium bicarbonate supplementation and placebo treatment
Blood pH (pH units) analysis carried out at baseline, and after SB and PLA supplementation
Time frame: Baseline and during 1 day of acute SB and PLA supplementation
Changes of lactate concentration in blood after sodium bicarbonate supplementation and placebo treatment
Lactate \[mmol/L\] concentration analysis carried out at baseline, and after SB and PLA supplementation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Baseline and during 1 day of acute SB and PLA supplementation
Changes of pyruvate concentration in blood after sodium bicarbonate supplementation and placebo treatment
Pyruvate \[mmol/L\] concentration analysis carried out at baseline, and after SB and PLA supplementation
Time frame: Baseline and during 1 day of acute SB and PLA supplementation
Changes in blood glucose concentration after sodium bicarbonate supplementation and placebo treatment
Glucose \[g/dl\] concentration analysis carried out at baseline, and after SB and PLA supplementation
Time frame: Baseline and during 1 day of acute SB and PLA supplementation
Changes in hemoglobin concentration after sodium bicarbonate supplementation and placebo treatment
Hemoglobin (Hb) \[g/dl\] concentration analysis carried out at baseline, and after SB and PLA supplementation
Time frame: Baseline and during 1 day of acute SB and PLA supplementation
Changes of blood cells concentration in blood after sodium bicarbonate supplementation and placebo treatment
Blood cells \[mln/mm³\] concentration analysis carried out at baseline, and after SB and PLA supplementation
Time frame: Baseline and during 1 day of acute SB and PLA supplementation
Changes of creatine kinase activity in blood after sodium bicarbonate supplementation and placebo treatment
Creatine kinase \[U/L\] activity analysis carried out at baseline, and after SB and PLA supplementation
Time frame: Baseline and during 1 day of acute SB and PLA supplementation
Changes of lactate dehydrogenase activity in blood after sodium bicarbonate supplementation and placebo treatment
Lactate dehydrogenase \[U/L\] activity analysis carried out at baseline, and after SB and PLA supplementation
Time frame: Baseline and during 1 day of acute SB and PLA supplementation